Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity

Background: High density lipoprotein (HDL) particles are heterogeneous in composition, structure, size, and may differ in conferring protection against cardiovascular disease. HDL associated enzyme, paraoxonase-1 (PON1), has an important role in attenuation of atherogenic low density lipoprotein (LD...

Full description

Bibliographic Details
Main Authors:	Amirnader Emami Razavi, Mohsen Ani, Morteza Pourfarzam, Gholam Ali Naderi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2012-01-01
Series:	Journal of Research in Medical Sciences
Subjects:	Dynamic light scattering high density lipoprotein size HDL-C paraoxonase-1 activity zetasizer
Online Access:	http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=11;spage=1020;epage=1026;aulast=Razavi

Similar Items

Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
by: Amirnader Emami Razavi, et al.
Published: (2013-06-01)

Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
by: Amirnader Emami Razavi, et al.
Published: (2013-06-01)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019-01-01)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
by: Diego Estrada-Luna, et al.
Published: (2018-10-01)

Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
by: Beekhof Piet K, et al.
Published: (2012-05-01)

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine
by: Yasemin Eren, et al.
Published: (2017-09-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
by: James P. Corsetti, et al.
Published: (2019-09-01)

Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), while Glycated HDL Lost the Antiviral Activity
by: Kyung-Hyun Cho, et al.
Published: (2021-02-01)

Atividade da paraoxonase / aril-esterase (PON) e incorporação de fosfolipídeos em partículas de HDL na hipertrigliceridemia humana
by: Vieira, Marcos Soares
Published: (2013)

Baculovirus-mediated expression and purification of human serum paraoxonase 1A
by: Robert J. Brushia, et al.
Published: (2001-06-01)

To Study the Activity of Paraoxonase-1 and High Density Lipoprotein-Cholesterol in Alcoholic Liver Cirrhosis
by: Pooja Nemagoudar, et al.
Published: (2017-01-01)

The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality
by: Malara Marzena, et al.
Published: (2016-05-01)

Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein
by: Maryam Boshtam, et al.
Published: (2013-01-01)

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
by: Huibi Cao, et al.
Published: (1999-01-01)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
by: Elisabet Rodríguez-Tomàs, et al.
Published: (2019-07-01)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
by: Sunil K Kota, et al.
Published: (2013-01-01)

Study of Serum Paraoxonase and High Density Lipoprotein Fractions in Diabetes
by: Arati Adhe-Rojekar, et al.
Published: (2018-03-01)

Influência da obesidade em adolescentes sobre a atividade da paraoxonase (PON1) e o tamanho da Lipoproteína de Alta Densidade (HDL)
by: Claudia Assef Sanibal
Published: (2012)

Influência da obesidade em adolescentes sobre a atividade da paraoxonase (PON1) e o tamanho da Lipoproteína de Alta Densidade (HDL)
by: Sanibal, Claudia Assef
Published: (2012)

The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status
by: Laura S. Rozek, et al.
Published: (2005-09-01)

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol effluxs⃞
by: Leonid Gaidukov, et al.
Published: (2006-11-01)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-06-01)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-01-01)

Association of serum paraoxonase activity with lipid profile, APO-A and APO-B in subjects with different levels of HDL
by: Maryam Teimouri, et al.
Published: (2018-11-01)

Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation[S]
by: Gerard Aragonès, et al.
Published: (2012-01-01)

Investigation of bovine serum albumin aggregation upon exposure to silver(i) and copper(ii) metal ions using Zetasizer
by: Alhazmi Hassan A., et al.
Published: (2021-09-01)

Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension
by: You-Cheol Hwang, et al.
Published: (2018-09-01)

Effect of four weeks of endurance training on serum level of paraoxonase-1 and lipid profile in non-athlete obese men
by: Amouzad Mahdirejei T, et al.
Published: (2014-07-01)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
by: Philip J. Barter
Published: (2013-09-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
by: Hamit Yasar Ellidag, et al.
Published: (2016-12-01)

High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
by: Knut Tore Lappegård, et al.
Published: (2021-07-01)

High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
by: Andrea Bonnin Márquez, et al.
Published: (2020-11-01)

Antioxidant properties of HDL
by: Handrean eSoran, et al.
Published: (2015-10-01)

L'extrait aqueux lyophilisé de Portulaca oleracea prévient contre la peroxydation lipidique en augmentant l'activité de la paraoxonase-1 sérique, chez des rats soumis à un régime enrichi en cholestérol [Aqueous extract of Portulaca oleracea prevents lipid peroxidation and increases serum paraoxonase-1 activity, in rats fed cholesterol enriched-diet]
by: Yahiaoui ZIDAN, et al.
Published: (2016-12-01)

Impact of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio on the risk factors for and outcome of ischemic stroke
by: Xin-wei BI, et al.
Published: (2014-10-01)

Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents
by: Sandor Raluca, et al.
Published: (2015-12-01)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
by: Alice Ossoli, et al.
Published: (2016-06-01)

Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease
by: Abdolkarim Mahrooz, et al.
Published: (2008-11-01)

Alterations in lipid transfer to High-Density Lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients Alterações na transferência de lípides para a lipoproteína de alta densidade (HDL) e atividade da paroxonase 1 em pacientes HIV+
by: Elaine Nunes Daminelli, et al.
Published: (2008-08-01)